Tag: capital

RBC Capital Sticks to Its Buy Rating for Knight Therapeutics (KHTRF)

Knight Therapeutics: A Promising Investment with Analysts and Insiders Aligning on Growth Potential Knight Therapeutics, a biopharmaceutical company, has recently gained attention from analysts and...

RBC Capital Keeps Their Buy Rating on Transcontinental (TCL.A)

Analyst's Positive Outlook on Transcontinental: A Closer Look In a recent update, RBC Capital analyst Drew Mcreynolds reaffirmed his confidence in Transcontinental (TCL.A) by maintaining...

Cintas (CTAS) Receives a Hold from RBC Capital

Analyst Maintains Hold Rating on Cintas with Optimistic Outlook In a recent report released yesterday, Ashish Sabadra from RBC Capital reaffirmed a "Hold" rating on...

RBC Capital Keeps Their Hold Rating on Paychex (PAYX)

Recent Analyst Update on Paychex: A Comprehensive Overview On , Ashish Sabadra, a senior analyst at RBC Capital, reaffirmed his "Hold" rating on Paychex (PAYX)...

RBC Capital Sticks to Its Hold Rating for Casey’s General (CASY)

A Comprehensive Overview of Casey's General Stock and Analyst Insights 1. An Introduction to Casey's General and Recent Analyst Insights Casey's General Stores, Inc. (CASY) is...

Popular Articles